Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology
Cardiorenal Medicine · 2024
DOI: 10.1159/000539075 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiorenal Medicine, 2024. Verfasst von Rose Mary Attieh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Northwell Health, New York, New York, USA. Hauptthemen laut MEDLINE: Cardiotoxicity, Antineoplastic Agents, Nephrology, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background: The evolving landscape of cancer treatments has introduced new challenges, particularly related to adverse events associated with chemotherapeutic agents. To address these challenges, the fields of cardio-oncology and onco-nephrology have arisen, focusing on the management of cardiotoxicity and nephrotoxicity attributable to anti-cancer drugs. Summary: Numerous intersections between these disciplines exist, including onco-hypertension (HTN) and cardiorenal toxicities induced by chemotherapeutic agents. Additionally, immune checkpoint inhibitors (ICIs) may cause myocarditis and nephritis. This paper aimed to explore the intersection between cardio-oncology and onco-nephrology. A detailed review will be undertaken, focusing on onco-HTN and the cardiorenal toxicities of chemotherapeutic agents, with a specific emphasis on the adverse effects associated with ICIs. Key Messages: Multidisciplinary collaboration among oncologists, cardiologists, nephrologists, and other healthcare professionals is crucial for developing tailored approaches to optimize treatment efficacy while minimizing the risk of cardiovascular and renal complications, ultimately enhancing patient outcomes in modern oncology practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Northwell Health, New York, New York, USA.
- Division of Kidney Diseases and Hypertension, Glomerular Center at Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA.
- Division of Nephrology, Lenox Hill Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, New York, USA.
- Cardiovascular Institute, Northwell Health, New York, New York, USA.
Zitieren
APA
Attieh, R. M., Nunez, B., Copeland-Halperin, R. S., & Jhaveri, K. D. (2024). Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology. Cardiorenal Medicine. https://doi.org/10.1159/000539075
Vancouver
Attieh RM, Nunez B, Copeland-Halperin RS, Jhaveri KD. Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology. Cardiorenal Medicine. 2024. doi:10.1159/000539075
BibTeX
@article{Attieh2024,
author = {Attieh, Rose Mary and Nunez, Belen and Copeland-Halperin, Robert S and Jhaveri, Kenar D},
title = {Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology},
journal = {Cardiorenal Medicine},
year = {2024},
doi = {10.1159/000539075}
}
EUVIMED